These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63 related articles for article (PubMed ID: 31656240)
1. Evaluation of immunogenicity and protective efficacy of bacteriophage conjugated haemagglutinin based subunit vaccine against equine influenza virus in a murine model. Kumar R; Bera BC; Anand T; Pavulraj S; Kurian Mathew M; Gupta RP; Tripathi BN; Virmani N Vet Res Commun; 2024 Jun; 48(3):1707-1726. PubMed ID: 38528300 [TBL] [Abstract][Full Text] [Related]
2. Monophosphoryl lipid A and poly I:C combination enhances immune responses of equine influenza virus vaccine. Lee DH; Lee J; Ahn SY; Ho TL; Kim K; Ko EJ Vet Immunol Immunopathol; 2024 May; 271():110743. PubMed ID: 38522410 [TBL] [Abstract][Full Text] [Related]
3. Formulation of Recombinant H1N1 Hemagglutinin in MF59 and Alum Adjuvants: A Comparison of the Vaccines Potency and Efficacy in BALB/C Mice. Sepasi A; Ghafourian M; Taghizadeh M; Mahdavi M Viral Immunol; 2023; 36(6):401-408. PubMed ID: 37504965 [TBL] [Abstract][Full Text] [Related]
4. Recombinant hemagglutinin of swine H1N1 influenza virus expression in the insect cells: Formulation in Montanide ISA71 adjuvant and the potency studies. Zahmati S; Taghizadeh M; Haghighat S; Jalalirad R; Mahdavi M Iran J Basic Med Sci; 2021 Nov; 24(11):1546-1553. PubMed ID: 35317113 [TBL] [Abstract][Full Text] [Related]
5. Immune responses and protective efficacy of American eel (Anguilla rostrata) immunized with a formalin-inactivated vaccine against Anguillid herpesvirus. Zhang LJ; Chen Q; Yang JX; Ge JQ Fish Shellfish Immunol; 2024 Jan; 144():109262. PubMed ID: 38040135 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of C. muridarum vaccines adjuvanted with CpG-1826 and four concentrations of Montanide-ISA-720-VG. Slepenkin A; Pal S; Rasley A; Coleman MA; de la Maza LM NPJ Vaccines; 2024 Jun; 9(1):104. PubMed ID: 38858418 [TBL] [Abstract][Full Text] [Related]
7. Development and evaluation of inactivated vaccines incorporating a novel Senecavirus A strain-based Immunogen and various adjuvants in mice. Wang B; Gao F; Hu R; Huyan H; Wang G; Cao Z; Zhao Y; Lu H; Song D; Gao F; He W; Lan Y Front Vet Sci; 2024; 11():1376678. PubMed ID: 38764852 [TBL] [Abstract][Full Text] [Related]
8. An Adjuvanted Vaccine-Induced Pathogenesis Following Influenza Virus Infection. Hsu SC; Lin KH; Tseng YC; Cheng YY; Ma HH; Chen YC; Jan JT; Wu CY; Ma C Vaccines (Basel); 2024 May; 12(6):. PubMed ID: 38932298 [TBL] [Abstract][Full Text] [Related]
9. Determination of the safety and efficacy of recombinant Chlamydia muridarum MOMP vaccines, formulated with CpG-1826 and 70%, 50%, 30% or 10% concentrations of Montanide ISA-720 VG, to elicit protective immune responses against a C. muridarum respiratory challenge. de la Maza L; Slepenkin A; Pal S; Rasley A; Coleman M Res Sq; 2023 Dec; ():. PubMed ID: 38168233 [TBL] [Abstract][Full Text] [Related]
10. Bestatin, A Pluripotent Immunomodulatory Small Molecule, Drives Robust and Long-Lasting Immune Responses as an Adjuvant in Viral Vaccines. Kim HW; Ko MK; Park SH; Shin S; Kim SM; Park JH; Lee MJ Vaccines (Basel); 2023 Nov; 11(11):. PubMed ID: 38006022 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of a new, inactivated canine adenovirus type 2 vaccine for dogs. Yang DK; Kim HH; Yoo JY; Ji M; Han BH; Oh S; Hyun BH Clin Exp Vaccine Res; 2020 Jan; 9(1):40-47. PubMed ID: 32095439 [TBL] [Abstract][Full Text] [Related]
16. Progress in the Development of Universal Influenza Vaccines. Sun W; Luo T; Liu W; Li J Viruses; 2020 Sep; 12(9):. PubMed ID: 32957468 [TBL] [Abstract][Full Text] [Related]
17. Protective efficacy of inactivated reverse genetics based equine influenza vaccine candidate adjuvanted with Montanide Mathew MK; Virmani N; Bera BC; Anand T; Kumar R; Balena V; Sansanwal R; Pavulraj S; Sundaram K; Virmani M; Tripathi BN J Vet Med Sci; 2019 Dec; 81(12):1753-1762. PubMed ID: 31656240 [TBL] [Abstract][Full Text] [Related]